Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name GELESIS INC Proposed Ticker GLSS CUSIP 36850R105 Business Description A biotechnology company focused on the development of first-in-class products to induce weight loss and improve glycemic control, or management of blood sugar levels, in overweight and obese patients, including those with prediabetes and type 2 diabetes. Lead Underwriter Guggenheim Securities, LLC, Piper Jaffray & Co., Stifel Nicolaus & Company, Incorporated Co-Managers N/A Initial Shares 4,000,000 Revised Initial Shares N/A Initial Price $12.00-$14.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.